Seeking Participants for Carcinoid Syndrome and Carcinoid Tumor Focus Groups in July
Schlesinger Associates, a leading medical marketing research specialist, is seeking patients diagnosed with Carcinoid Syndrome and Carcinoid Tumors to participate in small focus group interviews on the topic of Carcinoid Syndrome and associated…
READ MORE
Zebra Tales: Share Your Self-Care Story about Living with Carcinoid and Neuroendocrine Tumors
The Carcinoid Cancer Foundation and our partner Self Care Catalysts are pleased to launch Zebra Tales, a series of patient and caregiver stories about self-care while living with Carcinoid or other Neuroendocrine Tumors (NETs).
We are inviting you …
READ MORE
Acronyms Used in the Carcinoid and Neuroendocrine Tumor Community
Whether you are newly diagnosed, a friend or family member of a carcinoid/neuroendocrine tumor (NET) patient, or someone living with the disease for a long time, the language used in the carcinoid/NET community, especially the acronyms, can seem like…
READ MORE
Carcinoid NETs Health Storylines — Now Available in Seven Countries
The Carcinoid Cancer Foundation (CCF) and our partner Self Care Catalysts (SCC)…
READ MORE
May Luncheon with the Experts in New York City for the Carcinoid and Neuroendocrine Tumor Community
Join carcinoid and neuroendocrine tumor patients in New York City on Sunday, May 21, 2017 for a unique opportunity to have lunch with three medical experts. Share your experiences with others who have similar concerns and hear from physicians on issues…
READ MORE
STARTRK-2: A Basket Trial for Neuroendocrine Tumor Patients with Specific Gene Rearrangements
Precision medicine, molecular testing, basket studies, STARTRK-2 – it may sound like technology of the future but it is here today and it might be the answer to slowing or stopping tumor growth for neuroendocrine tumor (NET) patients who have specific…
READ MORE
Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)
The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.
PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST… READ MORE
Patient Education on Carcinoid Syndrome: From Diagnosis to Treatment
A Live Online Event on Wednesday, March 1, 11 am to 12 noon Eastern Standard Time
Ask Your Questions during the Live Program or Submit Them in Advance
Cancer Coach Live, in partnership with the Carcinoid Cancer Foundation, is presenting a special patient…
READ MORE
Neuroendocrine Tumors on TV: Rare Disease Day Special, February 28, 2017
NETs on TV! The Carcinoid Cancer Foundation has teamed up with The Balancing Act and Advanced Accelerator Applications to raise awareness about carcinoid and neuroendocrine tumors (NETs) during a feature on Lifetime TV on February 28 (Rare Disease…
READ MORE
April Luncheon with the Experts in White Plains, NY — Carcinoid and Neuroendocrine Tumor Patients Are Invited!
The Big Apple NETs support group invites you to join fellow carcinoid and neuroendocrine tumor (NET) patients and 3 medical experts for Lunch with the Experts on Sunday, April 2, 2017 at 12:00 pm at the Westchester Hills Golf Club, 401 Ridgeway Avenue, …
READ MORE
